An interventional study of Infant Formula - Partially hydrolyzed protein and Infant Formula - Intact protein in Fussy Infant (Baby), sponsored by Mead Johnson Nutrition. Completed at 11 sites in United States. Open to participants aged 15 Days to 75 Days. Per ClinicalTrials.gov, last updated 2025-06-18.
Sponsored by Mead Johnson Nutrition (part of Reckitt) · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
A multi-center, double-blind, controlled, parallel-designed, prospective trial intended to evaluate the nutritive effects of a partially hydrolyzed cow's milk protein infant formula on infant fussiness.
A multi-center, double-blind, controlled, parallel-designed, prospective trial intended to evaluate the nutritive effects of a partially hydrolyzed cow's milk protein (PHP) infant formula on infant fussiness. Formula tolerance and intake, sleep characteristics, stool characteristics, parental quality of life, and medically confirmed adverse events will be compared between i two study groups.
Mead Johnson Nutrition is the lead sponsor of 58 studies on the registry; 1 is open to participants now.
First submitted after Mead Johnson Nutrition became part of Reckitt.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Control
Other: Infant Formula - Intact protein
Investigational
Other: Infant Formula - Partially hydrolyzed protein
Partially hydrolyzed cow's milk protein
Intact cow's milk protein
Fussiness
Daily Diary
Time frame: Study Feeding Days 1 through 7
Fussiness
Daily Diary
Time frame: Study Feeding Days 8-28
Gassiness
Daily Diary
Time frame: Study Feeding Days 1-28
Crying
Daily Diary
Time frame: Study Feeding Days 1-28
Spit-up
Daily Diary
Time frame: Study Feeding Days 1-28
Sleep
Daily Diary
Time frame: Study Feeding Days 1-28
Stool frequency
Daily Diary
Time frame: Study Feeding Days 1-28
Stool consistency
Daily Diary
Time frame: Study Feeding Days 1-28
Study Formula Intake
24-hour Recall of Study Formula Intake
Time frame: Study Feeding Day 7 and Study Feeding Day 25 (+3 days)
Brief Infant Sleep Questionnaire
Revised Short Form (BISQ-R SF)
Time frame: Study Feeding Day 14 (+2 days) and Study Feeding Day 25 (+ 3 days)
Quality of Life Questionnaire
Pediatric Quality of Life Inventory™ Family Impact Module (PedsQL FIM)-Acute
Time frame: Study Feeding Day 7 (+2 days) and Study Feeding Day 25 (+3 days)
Medically confirmed adverse events
Collected from medical records
Time frame: Day 1 through end of feeding
Plan to share: No
No publications or documents are linked to this record.
Ran from Feb 2022 to primary completion in Jul 2023, 16 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.